Výsledky vyhledávání - "H, García del Río"

[Tc-99-sestamibi scan in the preoperative localization of abnormal hyperfunctioning parathyroid glands]

Autor: O D, Bruno, O J, Degrossi, H P, Curutchet, A A, Castellanos, M C, Alak, G, Arébalo-Cross, M, Montesinos, A J, García, H, García del Río, N A, Mezzadri

Publikováno v: Medicina. 56(5 Pt 1)

Hyperparathyroidism is a relatively frequent condition mostly due to a solitary parathyroid adenoma. Although it has been claimed that surgical exploration is the best way to visualize the abnormal parathyroid gland, several imaging techniques have b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::18c4aa5ef98f8cd51e3788dd81e5f784
https://pubmed.ncbi.nlm.nih.gov/9239878

Zobrazit plný text záznamu

Bioavailability of microencapsulated ferrous sulfate in fluid milk studies in human beings

Autor: C A, Gotelli, M J, Gotelli, J R, Boccio, M B, Zubillaga, R A, Caro, H, García del Río, R, Weill

Publikováno v: Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia. 46(4)

Iron deficiency is one of the most important nutritional problems in the world. The best method to overcome this problem is the fortification of foods with highly bioavailable iron. Fluid milk is a massive consumption food with an easy access and whi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d109898038bc8cbd88bd7c566c31bc03
https://pubmed.ncbi.nlm.nih.gov/9222389

Zobrazit plný text záznamu

Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover

Autor: E. Montuori, D. Messina, M. Ortiz, Eja Roldán, E. B. Degrossi, J. C. Barreira, O. J. Degrossi, Eduardo Kerzberg, H. García del Río, A. Pérez Lloret

Publikováno v: European journal of clinical pharmacology. 48(6)

The activity of olpadronate labelled with technetium-99m(99mTc) was monitored in plasma and urine samples after single oral (925 MBq 99mTc/10 mg, coadministered with 50 mg cold drug) and intravenous (925 MBq 99mTc/5 mg) administrations to two groups

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912d79a2439f1ee1ca6bb1b4b7277447
https://pubmed.ncbi.nlm.nih.gov/8582468

Zobrazit plný text záznamu

[Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas]

Autor: O J, Degrossi, I B, Rozados, S, Damilano, E B, Degrossi, L, de Ganino, M, Pinkas, H, García del Río, D, Artagaveytía

Publikováno v: Medicina. 51(4)

We have compared two "markers" in the follow up of post treatment (surgery and therapeutical use of I-131) differentiated thyroid carcinoma. In 153 patients, thyroglobulin (Tg) serum levels were measured after withdrawal of I-thyroxine therapy, befor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6ec951b1dd44fe620f4a09e95eca4c5d
https://pubmed.ncbi.nlm.nih.gov/1821916

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání